Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,546,468
+$1,165,286 QoQ
Shares Held
104,526
+0.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#634
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglass Winthrop Advisors, LLC holds $62,081,020 across 7 Drug Manufacturers - General names. JNJ ranks #2 (42.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,774 | $27,315,821 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
104,526 | $26,546,468 | |
| 3 | AMGN |
Amgen Inc
|
8,961 | $3,244,957 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
27,548 | $1,587,315 | |
| 5 | NVS |
Novartis AG
|
8,755 | $1,372,083 | |
| 6 | PFE |
Pfizer Inc
|
52,079 | $1,254,062 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,018 | $760,314 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,546,468 | 104,526 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $25,381,182 | 103,834 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $22,422,411 | 108,347 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $19,922,451 | 107,445 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,829,122 | 97,081 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,322,636 | 98,424 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,822,729 | 109,409 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $17,348,847 | 107,052 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $14,973,068 | 102,443 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $17,786,409 | 112,437 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $17,913,344 | 114,287 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $18,102,355 | 116,227 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $19,230,941 | 116,185 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,230,635 | 117,617 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,109,867 | 125,162 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $20,300,257 | 124,267 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $22,365,549 | 125,996 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $22,378,123 | 126,266 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,990,193 | 128,545 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $21,030,207 | 130,218 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $21,078,647 | 127,951 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $21,548,092 | 131,111 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $20,822,318 | 132,306 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $19,544,966 | 131,280 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $18,018,218 | 128,125 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $16,277,822 | 124,135 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||